Banner
Poster Presentations

Click on the topic below to view posters
CANCERClinical Outcomes Studies
PCN1  CELL PERMEABLE P27 (CP-P27) INDUCES APOPTOSIS IN CANCER CELLS. 
Park KM, Jo D
ProCell Therapeutics Inc, Gwangju, South Korea 
   
PCN2  DEVELOPMENT OF CELL PERMEABLE P18 AS A PROTEIN-BASED ANTI-CELL CYCLE PROGRESSION AGENT 
Kim S1, Park K2, Lim J2, Jo D1
1Chonnam National University, Gwangju, Jeonnam, South Korea, 2ProCell Therapeutics Inc, Gwangju, Jeonnam, South Korea 
   
CANCER Cost Studies
PCN3  ESTIMATING THE CLINICAL AND ECONOMIC IMPACT OF PROPHYLACTIC CERVICAL CANCER VACCINATION IN JAPAN USING A MARKOV MODEL 
Arakawa I1, Van Kriekinge G2, Demarteau N2, Fukuda T3
1GlaxoSmithKline K.K, Tokyo, Tokyo, Japan, 2GlaxoSmithKline Biologicals, Wavre, Belgium, 3The University of Tokyo, Tokyo, Tokyo, Japan 
   
PCN4  ECONOMIC EVALUATION OF SORAFENIB VS. BEST SUPPORTIVE CARE IN HEPATOCELLAR CARCINOMA IN SOUTH KOREA 
Jung S1, Hutchins V2, Muszbek N3, Chang M1, Shah S4
1Bayer Korea, Seoul, South Korea, 2United BioSource Corporation, Bethesda, MD, USA, 3United BioSource Corporation, London, United Kingdom, 4Bayer HealthCare Pharmaceuticals, West Haven, CT, USA 
   
PCN5  ECONOMIC EVALUATION OF CERVICAL CANCER PREVENTIONS AND CONTROL PROGRAMS IN THAILAND 
Praditsitthikorn N1, Riewpaiboon A2, Teerawattananon Y1
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand 
   
PCN6  COST-OF-ILLNESS ANALYSIS OF HEPATOCELLULAR CARCINOMA (HCC) IN SLOVAKIA BASED ON CALCULATION OF COSTS FROM HEALTH INSURANCE DATABASE 
Bielik J1, Lukac M2, Zatko D3, Foltán V4
1Trencin University, Trenčín, Slovak Republic, 2Bayer Schering Pharma, Bratislava, Slovak Republic, 3General Health Insurance, Bratislava, Slovak Republic, 4Comenius University, Bratislava, Slovak Republic 
   
PCN7  PATIENTS' WILLINGNESS TO PAY FOR A NEW DRUG TREATMENT OF LUNG CANCER 
Lang HC, Lan CF
National Yang-Ming University, Taipei, Taiwan 
   
PCN8  THE LIFETIME TREATMENT COST OF INVASIVE CERVICAL CANCER IN THAILAND 
Praditsitthikorn N1, Riewpaiboon A2, Chichareon S3, Teerawattananon Y1
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand, 3Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand 
   
PCN9  COST EFFECTIVENESS ANALYSIS OF NILOTINIB COMPARED WITH DASATINIB AND HIGH DOSE IMATINIB ON THE TREATMENT OF CHRONIC MYELOID LEUKEMIA 
Park SY1, Song HJ1, Lee JH2, Heo JH2, Lee EK1
1Sook Myung Women's University, Seoul, South Korea, 2Graduate school of pharmacy, SookMyung women's University, Seoul, Seoul, South Korea 
   
PCN10  THERAPEUTIC PATTERNS OF CARE FOR ADVANCED BREAST CANCER PATIENTS AFTER FAILURE OF AN ANTHRACYCLINE AND A TAXANE IN KOREA 
Choi SE, Kim S
Seoul National University, Seoul, South Korea 
 
CANCERPatient-Reported Outcomes Studies
   
PCN11  THE IMPACT OF THE PROJECT OF ENHANCING COVERAGE RATE FOR PATIENTS WITH CANCER 
Lee SM, Nam MH, Yoon SH, Kim BY, Choi MR, Cho HS, Lee KD
Health Insurance Review & Assessment Services, Seoul, South Korea 
   
PCN12  MEASURING UTILITY WEIGHTS FOR SEVERE STOMACH CANCER 
Kim HJ1, Rhee J2, Lee EK1
1Sook Myung Women's University, Seoul, South Korea, 2Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea 
   
PCN13  VALUATION OF THE ECONOMIC BENEFITS OF HUMAN PAPILLOMAVIRUS VACCINE IN TAIWAN 
Liao CH, Tang CH, Pwu RF, Chow I, Huang SY
Taipei Medical University, Taipei, Taiwan 
 
CANCERHealth Care Use & Policy Studies
PCN14  ASSESSING THE APPROPRIATNESS AND FEASIBILITY OF USING PET-CT SCAN IN THAILAND 
Yamabhai I, Praditsitthikorn N, Teerawattananon Y
Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand 
   
PCN15  BASIC ATTITUDE OF PHYSICIANS INVOLVED IN BREAST CANCER TREATMENT TOWARDS USE OF GENERIC ANTI-CANCERDRUGS IN JAPAN 
Saito S1, Shimozuma K2, Fukuda T3, Ohashi Y4, Fukui N5, Mouri M5
1Kochi Women's University, Kochi, Japan, 2University of Marketing and Distribution Sciences / Public Health Research Foundation, Kobe, Hyogo, Japan, 3Tokyo University, Tokyo, Japan, 4University of Tokyo, Bunkyo-ku, Tokyo, Japan, 5Japan Clinical Research Support Unit, Bunkyo-ku, Tokyo, Japan 
   
PCN16  PATTERN OF OPIOID USE AND ITS ASSOCIATION WITH HEALTHCARE SYSTEM AMONG OECD COUNTRIES: OXYCODONE-TO-MORPHINE RATIO 
Kim YA, Shin DW, Yun YH
National Cancer Center, Goyang-si, Gyeonggi-do, South Korea 
   
PCN17  CONSIDERATIONS ASSOCIATED WITH THE USE OF INTERIM DATA FOR REIMBURSEMENT SUBMISSIONS 
Delahoy PJ
Pfizer Australia, West Ryde, NSW, Australia 
   

CARDIOVASCULAR DISORDERS Clinical Outcomes Studies
   
PCV1  RACIAL/ETHNIC DIFFERENCES IN THE PREVALENCE OF METABOLIC SYNDROME AND IMPACT OF RACE/ETHNICITY ON OUTCOMES AMONG THOSE WITH METABOLIC SYNDROME 
Stankus AP, Saluja P
Consumer Health Sciences International, Princeton, NJ, USA 
   
PCV2  THE HEALTH OUTCOME AND BENEFITS OF CONTINUOUS BLOOD GAS MONITORING ADAPTATION 
Oláh A1, Varga G1, Müller Á1, Betlehem J1, Kriszbacher I1, Boncz I1, Sebestyén A2, Vas G1, Józsa R1, Bódis J1
1University of Pécs, Pécs, Hungary, 2National Health Insurance Fund Administration, Budapest, Hungary 
   
PCV3  CLINICAL OUTCOME AND COST EVALUATION OF THERAPEUTIC INTERCHANGE PROGRAM OF ANGIOTENSIN-RECEPTOER BLOCKERS IN HYPERTENSIVE PATIENTS 
Lin YY, Sun KL, Chien SC
Taipei Medical University Hospital, Taipei, Taiwan 
   
PCV4  IS STRESS THE TRIGGER OF A HEART ATTACK? 
Kriszbacher I, Bódis J, Betlehem J, Koppán Á, Kőhalmi A, Vas G, Vas B, Boncz I
University of Pécs, Pécs, Hungary 
   
PCV5  A STUDY OF THE ASSOCIATION BETWEEN COMBINED USE OF VARIOUS DIURETICS WITH DIGOXIN AND THE RISK OF HOSPITALIZATION FOR DIGOXIN INTOXICATION AMONG PATIENTS WITH CHRONIC HEART FAILURE IN TAIWAN 
Su CY, Wang MT
School of Pharmacy, National Defense Medical Center, Taipei, Taiwan 
   
PCV6  IS THE EXPOSURE TO DIGOXIN-CLARITHROMYCIN INTERACTION ASSOCIATED WITH AN INCREASED RISK OF HOSPITALIZATION FOR DIGOXIN TOXICITY AMONG PATIENTS WITH CHRONIC HEART FAILURE? 
Wang MT1, Su CY1, Chan ALF2
1School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, 2Department of Pharmacy, Chi Mei Medical Center, Tainan, Taiwan 
   
PCV7  ACUTE STROKE MANAGEMENT AND PATIENT SAFETY IN HUNGARY 
Betlehem J1, Veres R2, Kriszbacher I1, Olah A3, Sebestyen A4, Marton-Simora J5, Nagy G6, Vas G1, Bódis J1, Boncz I1
1University of Pécs, Pécs, Hungary, 2BAZ County Hospital, Miskolc, Hungary, 3University of Pecs, Pecs, Hungary, 4National Health Insurance Fund Administration, Pecs, Hungary, 5University of Pecs Faculty of Health Sciences, Pecs, Hungary, 6University of Pécs Faculty of Health Sciences, Pécs, Hungary 
 
CARDIOVASCULAR DISORDERS Cost Studies
   
PCV8  COST-EFFECTIVENESS ANALYSIS OF ANTIPLATELET THERAPY IN THE PREVENTION OF RECURRENT STROKE IN TAIWAN 
Chang YT, Chien SC
Taipei Medical University, Taipei, Taiwan 
   
PCV9  COST EFFECTIVENESS OF EZETIMIBE-SIMVASTATIN FIXED-DOSE COMBINATION VS ATORVASTATIN THERAPY IN KOREA 
Kim CM1, Kim M2, Cho E2, Gerth W3, Davies GM4
1Catholic University, Seoul, Suhcho-gu, South Korea, 2MSD Korea, Seoul, South Korea, 3Merck & Co., Inc, Whitehouse Station, NJ, USA, 4Merck and Co, Blue Bell, PA, USA 
   
PCV10  ASSESSING COST-EFFECTIVENESS OF STATINS FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN THAILAND 
Khonputsa P1, Tamteeranon Y2, Veerman L3, Vos T3, Lim S4, Chaikledkaew U5, Teerawattananon Y2
1Setting Priority using Information on Cost-Effectiveness (SPICE) Project, Nonthaburi, Thailand, 2Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 3University of Queensland, Brisbane, Australia, 4University of Washington, Seattle, WA, USA, 5Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand 
   
PCV11  COST-EFFECTIVENESS EVALUATION OF DIFFERENT STATIN TREATMENT STRATEGIES FROM THE THAI HEALTH SYSTEM PERSPECTIVE 
Anukoolsawat P1, Komolsai T2, Gandhi S3, Costa-Scharplatz M4
1Praram 9 Hospital, Bangkok, Thailand, 2AstraZeneca, Bangkok, Thailand, 3AstraZeneca, Wilmington, DE, USA, 4AstraZeneca, Södertälje, Sweden 
   
PCV12  COST EFFECTIVENESS OF CLINICAL PHARMACY SERVICES ON HYPERLIPIDAEMIC MANAGEMENT IN A PUBLIC HOSPITAL OF HONG KONG 
Lee VWY1, Chung JS1, Lee KK1, Tomlinson B2
1The Chinese University of Hong Kong, Shatin, Hong Kong, 2The Chinese University of Hong Kong, Hong Kong, China 
   
PCV13  AN ECONOMIC EVALUATION OF CLOPIDOGREL IN SECONDARY PREVENTION OF ISCHEMIC EVENTS IN HIGH-RISK POPULATIONS – A TAIWANESE ANALYSIS 
Li AH1, Annemans L2
1Far Eastern Memorial Hospital, Pan-Chiao, Taipei, Taiwan, 2Ghent University, Gent, Belgium 
   
PCV14  COST-EFFECTIVENESS ANALYSIS OF STROKE REHABILITATION STRATEGIES IN EASTERN CHINA 
O'Prinsen AC1, Redekop WK2
1Philips Research Asia, Shanghai, China, 2Erasmus Medical Center, Rotterdam, Netherlands 
PCV15  THE COST-EFFECTIVENESS OF ALISKIREN IN PATIENTS WITH HYPERTENSION : AN ADAPTATION IN KOREA 
Suh J, Kim S
Novartis, Seoul, South Korea 
   
PCV16  RELATIONSHIP BETWEEN THE BMI AND HEALTH CARE EXPENDITURES IN SUBJECTS WITH AND WITHOUT CARDIOVASCULAR DISEASE USING THE MEDICAL EXPENDITURE PANEL SURVEY 
Suh HS, Doctor JN
University of Southern California, Los Angeles, CA, USA 
   
CARDIOVASCULAR DISORDERSPatient-Reported Outcomes Studies
   
PCV17 EVALUATION OF QUALITY OF LIFE FOR PATIENTS RECEIVING ORAL ANTICOAGULATION IN TAIWAN 
Chu YW1, Tarn YH2
1Tri-Service General Hospital, Taipei, Taiwan, 2Center for Drug Evaluation, Taipei, Taiwan 
   
PCV18  WITHDRAWN
 
CARDIOVASCULAR DISORDERSHealth Care Use & Policy Studies
PCV19  THE IMPACT OF U.S. MEDICARE PRESCRIPTION DRUG COVERAGE ON MEDICATION USE PATTERNS AMONG THE ELDERLY 
Zhang Y, Donohue JM, Lave J
University of Pittsburgh, Pittsburgh, PA, USA 
   
PCV20  A RETROSPECTIVE EVALUATION OF STATINS UTILIZATION PATTERN IN 
Asuphol O1, Chaiyakunapruk N1, Poowaruttanawiwit P1, Jaengim S1, Jeanpeerapong N2, Jedsadayanmata A1
1Naresuan University, Muang, Phitsanulok, Thailand, 2Buddhachinnaraj Hospital, Muang, Phitsanulok, Thailand 
   
PCV21  WITHDRAWN
   
PCV22  UTILIZATION PATTERN OF DRUG ELUTING STENTS(DES), 2004~2007 
Song HJ1, Shin SY2
1Health Insuracne Review & Assessment Service, Seoul, South Korea, 2Health Insurance Review & Assessment Service, Seoul, South Korea 
   
PCV23  COMPARISON OUTCOMES BETWEEN DRUG-ELUTING STENTS AND BARE METAL STENTS: USING AN ADMINISTRATION DATA 
Shin SY1, Song HJ2
1Health Insurance Review & Assessment Service, Seoul, South Korea, 2Health Insuracne Review & Assessment Service, Seoul, South Korea 
   
PCV24  THE CHARACTERISTICS OF PREHOSPITAL CARE OF STROKE PATIENTS IN A SMALL REGION OF WESTERN-HUNGARY AFTER ACCESS TO EU 2005-2007 
Betlehem J1, Simon-Horvath L2, Nagy G1, Marton J1, Kriszbacher I1, Sebestyén A3, Oláh A1, Vas G1, Boncz I1
1University of Pécs, Pécs, Hungary, 2University of Pecs, Pecs, HI, Hungary, 3National Health Insurance Fund Administration, Budapest, Hungary 
   
PCV25  A LONGITUDINAL STUDY EXPLORING PRACTICE-MAKES-PERFECT EFFECT IN TAIWAN — USING CORONARY ARTERY BYPASS GRAFT AS AN EXAMPLE 
Chang YC1, Yang MC2
1Asia University, Taichung, Taiwan, 2National Taiwan University, Taipei, Taiwan 
   
PCV26  DRUG THERAPY PATTERNS AND CHANGES FOR PATIENTS WITH DIABETES ON ELEVATED TRIGLYCERIDES 
Ho HY, Livengood K, Ahn J
University of Southern California, Los Angeles, CA, USA 
   
DIABETES/ENDOCRINE DISORDERS Clinical Outcomes Studies
PDB1  THE SAFETY OF METFORMIN USE IN TYPE 2 DIABETES PATIENTS WITH HEART FAILURE 
Pao LH1, Su RY1, Kou CW2
1National Defense Medical Center, Taipei, Taiwan, 2Cheng Hsin Rehabilitation Medical Center, Taipei, Taiwan 
 
DIABETES/ENDOCRINE DISORDERS Cost Studies
PDB2  COST-EFFECTIVENESS ANALYSIS OF VOGLIBOSE IN PREVENTION OF TYPE 2 DIABETES IN JAPANESE WITH IMPAIRED GLUCOSE TOLERANCE (IGT) 
Ikeda S1, Kobayashi M2, Tajima N3
1International University of Health and Welfare, Ohtawara, Tochigi, Japan, 2Crecon Research and Consulting Inc, Shibuya-ku, Tokyo, Japan, 3Jikei University School of Medicine, Minato-ku, Tokyo, Japan 
   
PDB3  COST-EFFECTIVENESS ANALYSIS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR TYPE 2 DIABETIC PATIENTS IN SAUDI ARABIA 
Ali M1, White J2, Nielsen S3, Fakhoury W4, Palmer JL5, Valentine WJ5
1IMS Health, Riyadh, Saudi Arabia, Riyadh, Saudi Arabia, 2Novo Nordisk International Operations A/S, Zurich, Switzerland, 3Novo Nordisk A/S, Virum, Denmark, 4IMS Health, London, United Kingdom, 5IMS Health, Basel, Switzerland 
   
PDB4  COST-EFFECTIVNESS ANALYSIS OF BIPHASIC INSULIN ASPART IN TYPE 2 DIABETICS IN CHINA: RESULTS FROM AN OBESERVATIONAL STUDY 
White J1, Lynch M2, Jing L3
1Novo Nordisk International Operations A/S, Zurich, Switzerland, 2IMS Health, Shanghai, China, 3Novo Nordisk (China) Pharmaceuticals Co. Ltd, Beijing, China 
   
PDB5  COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR TYPE 2 DIABETIC PATIENTS IN SOUTH KOREA 
Lee KH1, White J2, Nielsen S3
1IMS Health, Korea, Seoul, South Korea, 2Novo Nordisk International Operations A/S, Zurich, Switzerland, 3Novo Nordisk A/S, Virum, Denmark 
   
PDB6  POSSIBLE COST SAVINGS IN TAIWAN: SELF-MEASUREMENT OF BLOOD GLUCOSE IN TYPE 2 DIABETES PATIENTS (ROSSO STUDY NO. 15) 
Neeser K1, Weber C1, Kocher S1, Schneider B2
1Institute for Medical Informatics and Biostatistics, Basel, Switzerland, 2Medical University of Hannover, Hannover, Germany 
   
PDB7  DIRECT MEDICAL COSTS OF TYPE 2 DIABETIC PATIENTS IN THE TERTIARY HOSPITAL 
Hwang JA1, Park TC1, Jung SH2, Kim HJ1, Kim DJ1, Kim SH3, Nam M3, Kim TH4, Lee MK4, Lee KW1
1Ajou University School of Medicine, Suwon, South Korea, 2Pochon CHA University, Seoul, South Korea, 3Inha University School of Medicine, Incheon, South Korea, 4Sungkyunkwan University School of Medicine, Seoul, South Korea 
   
PDB8  DIRECT MEDICAL COSTS OF TYPE 2 DIABETIC PATIENTS IN KOREA : COST ANAYLSIS FROM THE KOREAN NATIONAL DIABETES PROGRAM 
Kim HJ1, Kim TH1, Han SJ1, Kim DJ1, Chun KH1, Kim YS2, Woo JT2, Baik SH3, Park YS4, Nam M5, Kim SH6, Ahn K2, Lee KW1
1Ajou University School of Medicine, Suwon, South Korea, 2Kyung Hee University College of Medicine, Seoul, South Korea, 3Korea University College of Medicine, Seoul, South Korea, 4Hanyang University College of Medicine, Guri, South Korea, 5In Ha University College of Medicine, Incheon, South Korea, 6Kwandong University Collage of Medicine, Seoul, South Korea 
   
PDB9  INCREMENTAL TREATMENT COSTS ATTRIBUTABLE TO OBESITY IN PATIENTS WITH DIABETES MELLITUS IN THE U.S. 
Suh DC1, Jang EJ1, Kim CM2, Jung JC3, Jang SM4
1Rutgers University, Piscataway, NJ, USA, 2Catholic University, Seoul, Suhcho-gu, South Korea, 3Korea National Health Insurance Corporation, Mapo-gu, Seoul, South Korea, 4Health Insurance Review & Assessment Service, Seoul, South Korea 
 
DIABETES/ENDOCRINE DISORDERS Patient-Reported Outcomes Studies
PDB10  EFFECT OF ANTIHYPERGLYCEMIC MEDICATION ADHERENCE ON HOSPITALIZATION AND HEALTHCARE COST 
Jang SM1, Park IB2, Suh DC3, Moon KT4, Kim CM5, Kim JY4
1Health Insurance Review & Assessment Service, Seoul, South Korea, 2Gachon University, Incheon, Incheon, South Korea, 3Rutgers University, Piscataway, NJ, USA, 4Health Insurance Review & Assessment Service, Seoul, Seoul, South Korea, 5Catholic University, Seoul, Suhcho-gu, South Korea 
   
PDB11  WITHDRAWN
   
PDB12  TRANSFERABILITY OF PATIENT REPORTED OUTCOMES IN DIABETES: CULTURAL DIFFERENCES IN JAPAN 
Crawford B1, Palmer S2, Boye KS3, Breugelmans R4, Mear I5
1Mapi Values, Tokyo, Meguro, Japan, 2Mapi Values, Boston, MA, USA, 3Eli Lilly and Company, Indianapolis, IN, USA, 4Tokyo Medical University, Shinjuku, Tokyo, Japan, 5Mapi Research Institute, Lyon, France 
   
DIABETES/ENDOCRINE DISORDERS Health Care Use & Policy Studies
PDB13  WITHDRAWN
   
PDB14  INITIAL IMPROVEMENT IN GLYCAEMIC CONTROL AMONGST NEW TYPE 2 DIABETIC PATIENTS 
Govinda Raj A, Toh MP, Heng BH
National Healthcare Group, Singapore, Singapore, Singapore 
   
PDB15  DO PATIENTS WITH MULTIPLE CHRONIC CONDITIONS RECEIVE LOWER QUALITY OF CARE? 
Bae S1, Rosenthal M2
1Health Insurance Review and Assessment Service, Seoul, South Korea, 2Harvvard School of Public Health, Boston, MA, USA 
   
GASTROINTESTINAL DISORDERS Health Care Use & Policy Studies
PGI1  WITHDRAWN
   
PGI2  ARE ALL ALGINATES REALLY THE SAME? A COMPARISON OF ALGINATE SWITCHING PATTERNS IN A LARGE LONGITUDINAL UK DATABASE 
Bhatt A1, Connolly M2
1Reckitt Benckiser (Healthcare), Hull, United Kingdom, 2Global Market Access Solutions, St Prex, Switzerland 
PGI3 VALIDITY OF THE KOREAN VERSION OF THE CHRONIC LIVER DISEASE QUESTIONNAIRE (CLDQ) FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN KOREAN PATIENTS WITH CHRONIC HEPATITIS B
  Choi HM1, Kwon SY2, Kim Y1, Koo HW1, Choi W1, Lee YS1, Lee YS3, Lee JH4, Lee CH2
1GlaxoSmithKline, Seoul, South Korea, 2Konkuk University, Seoul, South Korea, 3Catholic University of Korea, Bucheon, South Korea, 4Sungkyunkwan University, Seoul, South Korea
   
HEALTH CARE USE & POLICY STUDIESConsumer Role in Health Care
PHP1  ASSOCIATION BETWEEN DIRECT-TO-CONSUMER ADVERTISING (DTCA) AND DRUG UTILIZATION IN THE U.S. MEDICAID MARKET FOR SELECTED DRUG CLASSES 
Sheridan J1, Guo JJ2, Kelton CM2, Shelly D3
1Medpace Reference Laboratories, Cincinnati, OH, USA, 2University of Cincinnati, Cincinnati, OH, USA, 3Meridian Life Science, Inc, Cincinnati, OH, USA 
   
HEALTH CARE USE & POLICY STUDIESDrug/Device/Diagnostic Use & Policy
PHP2  KOREAN EXPERIENCE OF UTILIZING MEDICAL MATERIALS 
Song HJ1, Shin SY2
1Health Insuracne Review & Assessment Service, Seoul, South Korea, 2Health Insurance Review & Assessment Service, Seoul, South Korea 
   
PHP3  ESTIMATION OF FINANCIAL BURDEN DUE TO OVER POSSESSION OF CHRONIC DISEASE MEDICATIONS 
Chaiyakunapruk N1, Thanarungroj A1, Cheewasithirungrueng N1, Nimpitakpong P1, Jeanpeerapong N2, Meepadung J2, Srisupha-olarn W3
1Naresuan University, Muang, Phitsanulok, Thailand, 2Buddhachinnaraj Hospital, Muang, Phitsanulok, Thailand, 3Naresuan University Phayao, Muang, Phayao, Thailand 
   
PHP4  ARE KEY INFORMANTS' OPINIONS ABOUT DRUG SAMPLES CONCORDANT WITH THEIR WISH LIST FOR A NEW DISTRIBUTION SYSTEM? 
Kyle GJ, Nissen LM, Tett SE
The University of Queensland, St Lucia, QLD, Australia 
   
PHP5  MOVING TOWARDS EVIDENCE BASED MEDICINE AS A PLATFORM FOR THE REIMBURSEMENT OF PROSTHESES IN AUSTRALIA. 
Glase KM, O'Leary BA
Covance Pty Ltd, Sydney, NSW, Australia 
   
PHP6  REVIEW OF ALCOHOL POLICIES AND CONTRIBUTIONS FROM KEY PLAYERS IN REDUCING ALCOHOL CONSUMPTION BETWEEN 1997-2007 IN THAILAND 
Yothasamut J1, Youngkong S1, Teerawattananon Y1, Tantivess S1, Thavorncharoensap M1, Chaikledkaew U2, Lertpitakpong C1, Mohara A1, Kingkaew P1, Yamabhai I1
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand 
   
PHP7  EVALUATING A GENERIC FIRM'S INCENTIVES TO CHALLENGE THE PATENTS OF AN ORIGINATOR DRUG: LEGISLATIVE CHANGE, PATENT CONDITIONS, AND MARKET SIZE 
Rhee J
Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea 
   
PHP8  HERB/DIETARY SUPPLEMENT AND PRESCRIPTION DRUG USE TRENDS AMONG US ADULTS, 1999-2004 
Lin HW1, Wittenberg RD2, Shaw JW2, Tsai HH3, Pickard AS4
1China Medical University, Taichung, Taiwan, 2University of Illinois at Chicago, Chicago, IL, USA, 3China Medical University, Taichung, Taiwan, Changhua City, Changhua County, Taiwan, 4College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA 
   
PHP9  UTILIZATION OF ERYTHROPOIESIS-STIMULATING AGENTS IN CRITICAL CARE SETTING IN U.S HOSPITALS: A RETROSPECTIVE STUDY 
Lee SP1, Holdford D2, Brophy GM2, Brophy DF2, Brophy DF2
1Thomas Jefferson University, Philadelphia, PA, USA, 2Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA 
   
PHP10  HOW THE BLIND COPE WITH PROBLEMS OF MEDICINE UTILIZATION 
Riewpaiboon A
Faculty of Pharmacy Mahidol University, Ratchathevi, Bangkok, Thailand 
   
PHP11  PRINCIPAL COMPONENTS ANALYSIS OF DRUG UTILIZATION AND EXPENDITURE TRENDS FOR MAJOR THERAPEUTIC CLASSES IN U.S. MEDICAID PROGRAMS 
Jing Y1, Nguyen K1, Fan H2, Kelton CM1, Li X3, Guo JJ1
1University of Cincinnati, Cincinnati, OH, USA, 2Covance Inc, Sun Prairie, WI, USA, 3UC, 121212, NJ, USA 
   
HEALTH CARE USE & POLICY STUDIESDisease Management
PHP12  ROAD TRAFFIC INJURY AND ITS PREVENTION IN MONGOLIA 
Munkhtuvshin O
National Center for Health Development, Ulaanbaatar, Mongolia 
HEALTH CARE USE & POLICY STUDIES Equity and Access
PHP13  HEALTH RISK DISTRIBUTION BY SOCIO-ECONOMIC STATUS AND EDUCATIONAL LEVELS OF THAI HOUSEHOLDS: WHO SMOKE AND DRINK MORE? 
Chokevivat V1, Limwattananon S2, Bundhamcharoen K3, Prakongsai P3, Tangcharoensathien V4
1The Government Pharmaceutical Organisation Board, Bangkok, Bangkok, Thailand, 2Khon Kaen University, Khon Kaen, Khon Kaen, Thailand, 3International Health Policy Program (IHPP), Nonthaburi, Nonthaburi, Thailand, 4International Health Policy Program - Thailand, Nonthaburi, Thailand 
   
HEALTH CARE USE & POLICY STUDIESHealth Care Costs & Management
PHP14  INPATIENT LENGTH OF STAY AND TOTAL COSTS OF ILLNESSES OF PRESSING CONCERN FOR ASIAN-AMERICAN AND PACIFIC ISLANDER WOMEN IN THE UNITED STATES 
Candrilli SD1, Davis KL2, Balkrishnan R1
1The Ohio State University, Columbus, OH, USA, 2RTI Health Solutions, Research Triangle Park, NC, USA 
   
PHP15  IRREGULAR WORKER AND HEALTH EXPENDITURE IN KOREA 
Park EJ
Korea Institute for Health and Social Afffairs, Seoul, South Korea 
   
PHP16  THE SOCIOECONOMIC COST OF ILLNESS IN KOREA: 2001~2005 
Jung YH
Korea Institute for Health and Social Affairs, Seoul, South Korea 
   
PHP17  BALANCING THE BUDGET OF THE HUNGARIAN NATIONAL HEALTH INSURANCE FUND ADMINISTRATION (OEP) IN 2007 
Boncz I1, Sebestyén A2, Ágoston I1, Vas G1, Gulácsi L3, Betlehem J1, Oláh A1, Kriszbacher I1
1University of Pécs, Pécs, Hungary, 2National Health Insurance Fund Administration, Budapest, Hungary, 3Corvinus University of Budapest, Budapest, Hungary 
   
PHP18  CHALLENGING THE 50,000 $ THRESHOLD: ADJUSTMENT OF THE COST-EFFECTIVENESS THRESHOLD BY COUNTRY SPECIFIC FACTORS. THE EXAMPLE OF THE ASIA-PACIFIC REGION 
Weber C, Neeser K
Institute for Medical Informatics and Biostatistics, Basel, Switzerland 
   
PHP19  FINANCING HEALTH PROMOTION IN SOUTHEAST ASIA– DOES IT MATCH WITH CURRENT AND FUTURE CHALLENGES? 
Prakongsai P1, Bundhamcharoen K1, Tisayatikom K2, Tangcharoensathien V2
1International Health Policy Program (IHPP), Nonthaburi, Nonthaburi, Thailand, 2International Health Policy Program - Thailand, Nonthaburi, Thailand 
   
PHP20  COST OF OUT PATIENTS CARE AT THE BASIC HEALTH UNITS IN PAKISTAN (NORTH WEST FRONTIER PROVINCE AND TRIBAL AREAS) DURING 2005 
Malik AM
Aga Khan Univeristy, Karachi, Pakistan 
   
PHP21  ECONOMIC-BASED OUTCOMES ASSESSMENT OF PHARMACEUTICAL CARE IN A UNIVERSITY HOSPITAL MEDICAL INTENSIVE CARE UNIT IN TAIWAN 
Huang CY1, Hao HS2, Tsai HY2, Hsieh YW1
1China Medical University Hospital, Taichung, Taiwan, 2China Medical University, Taichung, Taiwan 
   
PHP22  WITHDRAWN
   
PHP23  ESTABLISHMENT OF HUMAN STEM CELL LINES WITH CELL PERMEABLE NANOG AND OCT4 (CP-NANOG AND CP-OCT4) 
Kang W, Ahn TY, Jo D
Chonnam National University Medical School, Gwangju, South Korea 
   
PHP24  RACIAL/ETHNIC DIFFERENCES IN THE HEALTHCARE ATTITUDES, PRACTICE OF COST-CUTTING STRATEGIES, AND SOURCES OF HEALTHCARE INFORMATION 
Stankus AP, Saluja P
Consumer Health Sciences International, Princeton, NJ, USA 
   
PHP25  PREFERENCES FOR DRUG REIMBURSEMENT CRITERIA IN SOUTH KOREA USING DISCRETE CHOICE EXPERIMENTS 
Lim MK1, Bae EY2
1Health Insurance Review & Assessment Service, Seoul, South Korea, 2Sangji University, Gangwondo, South Korea 
   
PHP26  COST RECOVERY OF MEDICAL REHABILITATION SERVICES UNDER THE UNIVERSAL HEALTH COVERAGE SCHEME AT UDONTHANI HOSPITAL 
Pattanaphesaj J1, Riewpaiboon A2, Riewpaiboon W3, Muenpol P4, Paileeklee S4, Tungjaroen D4, Krutjaikla B4
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathevi, Bangkok, Thailand, 3Sirindhorn National Medical Rehabilitation Center, Nonthaburi, Thailand, 4Udonthani Hospital, Udonthani, Thailand 
   
PHP27  THE EFFECT OF THE PERFORMANCE VOLUME LIMIT (PVL) ON THE PATIENT ADMISSIONS OF THE HUNGARIAN HOSPITALS 
Boncz I1, Sebestyén A2, Ágoston I1, Nagy Z3, Vas G1, Gulácsi L4, Oláh A1, Betlehem J1, Kriszbacher I1
1University of Pécs, Pécs, Hungary, 2National Health Insurance Fund Administration, Budapest, Hungary, 3Health Insurance Supervisory Authority, Budapest, Hungary, 4Corvinus University of Budapest, Budapest, Hungary 
   
PHP28  UTILITIES ARE NOT ALL THE SAME – HOW REIMBURSEMENT AGENCIES VARY IN THEIR DESIRE FOR UTILITIES 
Lloyd A
Oxford Outcomes, Oxford, United Kingdom 
   
PHP29  WITHDRAWN
   
HEALTH CARE USE & POLICY STUDIESHealth Care Research & Education
PHP30  PROTEIN-BASED NEW DRUG DISCOVERY/DEVELOPMENT USING MACROMOLECULE INTRACELLULAR TRANSDUCTION TECHNOLOGY (MITT) 
Jo D
ProCell Therapeutics, Inc./Chonnam National University Medical School, Gwangju, Gwangju, South Korea 
 
HEALTH CARE USE & POLICY STUDIESPrescribing Behavior & Treatment Guidelines
PHP31  THE PRESCRIBING OF CHINESE HERBAL PRODUCTS IN TAIWAN: A CROSS-SECTIONAL ANALYSIS OF THE NATIONAL HEALTH INSURANCE REIMBURSEMENT DATABASE 
Hsieh SC1, Lee CF2, Wang JD3
1Center for Drug Evaluation, Taipei City, Taiwan, 2Tri-Service General Hospital, Taipei, Taiwan, 3National Taiwan University, Taipei, Taiwan 
 
HEALTH CARE USE & POLICY STUDIESRegulation of Health Care Sector
PHP32  INTRODUCTION OF HEALTH-ECONOMICS INTO GOVERNMENTAL DECISION MAKING ON DRUG REIMBURSEMENT IN HUNGARY 
Nagy Z1, Sebestyén A2, Vas G3, Ágoston I3, Kriszbacher I3, Oláh A3, Boncz I3
1Health Insurance Supervisory Authority, Budapest, Hungary, 2National Health Insurance Fund Administration, Budapest, Hungary, 3University of Pécs, Pécs, Hungary 
   
PHP33  OVERVIEW AND COMPARISON OF DRUG SAFETY SURVEILLANCE IN DEVELOPING COUNTRIES 
Guo JJ1, Vaidya S1, Jing Y1, Du W2
1University of Cincinnati, Cincinnati, OH, USA, 2Shanghai Food Drug & Administration, Shanghai, Shanghai, China 
   
PHP34  COMPARING THE LEGAL BACKGROUND OF HOSPITAL BED REDUCTION IN HUNGARY IN 1996 AND IN 2007 
Ágoston I1, Sebestyén A2, Nagy Z3, Vas G1, Kriszbacher I1, Boncz I1
1University of Pécs, Pécs, Hungary, 2National Health Insurance Fund Administration, Budapest, Hungary, 3Health Insurance Supervisory Authority, Budapest, Hungary 
   
PHP35  THE EFFECT OF CURRENT (2007) HEALTH CARE REFORMS ON THE NUMBER OF HOSPITAL BEDS IN HUNGARY 
Vas G1, Sebestyén A2, Ágoston I1, Nagy Z3, Kriszbacher I1, Betlehem J1, Vas B1, Boncz I1
1University of Pécs, Pécs, Hungary, 2National Health Insurance Fund Administration, Budapest, Hungary, 3Health Insurance Supervisory Authority, Budapest, Hungary 
 
INDIVIDUAL'S HEALTH Clinical Outcomes Studies
PIH1  COMPARETIVE EFFECTIVENESS AND SAFETY OF TWO MONOPHASIC ORAL CONTRACEPTIVES OF MARVELON AND MINULET 
Wang L1, Peng L1, Li Y2
1Sichuan University, Chengdu, Sichuan, China, 2West China Hospital, Sichuan University, Chengdu, China 
   
INDIVIDUAL'S HEALTH Cost Studies
PIH2  BUDGET IMPACT OF THE THALASSEMIA MANAGEMENT UNDER THE NATIONAL HEALTH SECURITY SCHEME 
Bunyadharokul S1, Riewpaiboon A2, Chaikledkaew U3, Torcharus K4
1Mahidol University, Ratchathewi District, Bangkok, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand, 3Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 4Phramongkutklao Hospital, Ratchathewi, Bangkok, Thailand 
   
PIH3  ECONOMIC EVALUATION OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN TAIWAN: A COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL INFANT VACCINATION 
Wu D1, Rinaldi F2, Huang YC3, Chang CJ4
1Department of Biological Statistics, Institute of Public Health, National Yang-Min University, Taipei, Taiwan, 2Wyeth Australia Pty. Ltd, Sydney, NSW, Australia, 3Department of Pediatrics, Chang-Gung Memorial Hospital, Taoyuan, Taiwan, 4Graduate Institute of Clinical Medical Sciences,Chang Gung University, Taoyuan, Taiwan 
   
PIH4  ESTIMATING THE TREATMENT COSTS OF MENOPAUSE-RELATED SYMPTOMS IN TAIWAN 
Huang SY, Tang CH, Hung ST, Chow I, Chang CL, Liao CH
Taipei Medical University, Taipei, Taiwan 
   
INDIVIDUAL'S HEALTH Patient-Reported Outcomes Studies
PIH5  QUALITY OF LIFE IN TRANSFUSION DEPENDENT THALASSAEMIA PATIENTS ON DESFERRIOXAMINE TREATMENT AT HOSPITAL UNIVERSITI KEBANGSAAN MALAYSIA AND HOSPITAL KUALA LUMPUR. 
Dahlui M1, Aljunid SM2, Ibrahim HS3
1University Malaya, Kuala Lumpur, Malaysia, 2Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia, 3Paediatric Intitute, Kuala Lumpur, Malaysia 
   
PIH6  THE IMPACT OF HEALTH STATE SELECTION ON EQ-5D VALUATION - A STUDY BASED ON KOREAN VALUATION SET 
Chuang LH1, Nam HS2, Kind P1
1University of York, York, United Kingdom, 2College of Medicine, Chungnam National University, Daejeon, South Korea 
   
INDIVIDUAL'S HEALTHHealth Care Use & Policy Studies
PIH7  WITHDRAWN                                                                                                        
   
INFECTION Clinical Outcomes Studies
PIN1  ANTIBIOTIC IMPACT ON HOSPITAL LENGTH OF STAY AND COSTS AMONG INPATIENT COMMUNITY ACQUIRED PNEUMONIA (CAP) PATIENTS 
Ye X1, Sikirica V2, Benson C3, Doshi D4, Schein JR3, Raut M3, Riedel AA1
1i3 Innovus, An Ingenix Company, Eden Prairie, MN, USA, 2ETHICON, Inc, Somerville, NJ, USA, 3Ortho-McNeil Janssen Scientific Affairs, LLC, Raritan, NJ, USA, 4Ortho-McNeil Janssen Scientific Affairs, LLC, San Diego, CA, USA 
   
PIN2  EFFECTIVENESS AND SAFETY OF ZIDOVUDINE FOR PREVENTING THE RISK OF MOTHER-TO-CHILD TRANSMISSION OF HIV: A SYSTEMATIC REVIEW 
Wang L1, Li Y2, Sun X2
1Sichuan University, Chengdu, Sichuan, China, 2West China Hospital, Sichuan University, Chengdu, China 
   
PIN3  EFFECTIVENESS AND SAFETY OF NEVIRAPINE FOR PREVENTING THE RISK OF MOTHER-TO-CHILD TRANSMISSION OF HIV: A SYSTEMATIC REVIEW 
Wang L1, Li Y2
1Sichuan University, Chengdu, Sichuan, China, 2West China Hospital, Sichuan University, Chengdu, China 
INFECTION Cost Studies
PIN4  COST-EFFECTIVENESS OF VACCINATION AGAINST SEASONAL INFLUENZA: A REALISTIC-AGE-STRUCTURED DETERMINISTIC COMPARTMENTAL MODEL 
Thompson WA1, Eggington SG1, Tucker D2
1IMS Health, London, United Kingdom, 2GlaxoSmithKline Biologicals, Wavre, Belgium 
   
PIN5  ECONOMIC EVALUATION OF ROUTINE 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION OF INFANTS IN THE ASIA-PACIFIC: LESSONS LEARNED FROM HONG KONG, SINGAPORE AND TAIWAN 
Rinaldi F
Wyeth Australia Pty. Ltd, Sydney, NSW, Australia 
   
PIN6  COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION OF THE ELDERLY: A STUDY USING NATIONAL HEALTH INSURANCE DATABASE IN SOUTH KOREA, 2005. 
Kim SA1, Lee SY2, Batmunkh N3, Kilgore PE3, Ki MR4
1International Vaccine Institute; Graduate School of Public Health, Seoul National University, Seoul, South Korea, 2Health Insurance Research Center, Seoul, South Korea, 3International Vaccine Institute, Seoul, South Korea, 4Eulji University School of Medicine, Daejeon, South Korea 
   
PIN7  COST-EFFECTIVENESS ANALYSIS OF OSELTAMIVIR FOR INFLUENZA IN JAPAN: MODELING IN THE VIRUS EMERGING RESISTANT TO THE DRUG 
Nagase H1, Kamae M2, Moriwaki K3, Yanagisawa S3, Kamae I4
1Kobe University School of Medicine, Kobe, Hyogo, Japan, 2Tufts-NEMC, U.S.A, Boston, MA, USA, 3Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan, 4Kobe University Graduate School of Medicine, Kobe, Japan 
   
PIN8  ECONOMIC EVALUATION OF DIFFERENT TREATMENTS OF CHRONIC HEPATITIS B IN CHINA 
Lacey L1, Lu XZ2, Tan-Mulligan A3
1LaceySolutions Ltd, Dublin County, Ireland, 2GlaxoSmithKline, Shanghai, China, 3GlaxoSmithKline China, Shanghai, China 
   
PIN9  AN ECONOMIC EVALUATION OF THE POTENTIAL IMPACT OF EMERGING VACCINE TECHNOLOGIES ON MEASLES COST AND DISEASE BURDEN IN TWO ASIAN SETTINGS 
Garrison L1, Bauch CT2, Bresnahan B1, Hazlet TK1, Kadiyala S1, Veenstra DL1
1University of Washington, Seattle, WA, USA, 2University of Guelph, Guelph, ON, Canada 
   
PIN10  MONOTHERAPY VERSUS COMBINATION THERAPY IN INTRA-ABDOMINAL INFECTIONS: COST-EFFECTIVENESS STUDY FROM INDIA 
Kochhar P1, Suvarna V1, Duttagupta S2, Sarkar S1
1Pfizer India, Mumbai, India, 2Pfizer Inc, New York, NY, USA 
   
PIN11  ECONOMIC EVALUATION OF TREATMENT ADMINISTRATION STRATEGIES OF GANCICLOVIR FOR CYTOMEGALOVIRUS RETINITIS IN HIV/AIDS PATIENTS IN THAILAND 
Teerawattananon K
Health Intervention and Technology Assessment Program (HITAP), Muang, Nonthaburi, Thailand 
 
PIN12 A COST MINIMIZATION ANALYSIS COMPARING DIFFERENT ANTIBIOTIC REGIMENS USED IN TREATING PNEUMONIA IN HONG KONG
Lee KK, Chau MW, Fan BS, Wan MH, Lee VWY
The Chinese University of Hong Kong, Shatin, Hong Kong /td>
   
PIN13  THE CLINICAL AND ECONOMIC BURDEN OF ROTAVIRUS INFECTION IN KOREA
Yang BM1, Jo DS2, Kim YH1, Hong JM1, Kim JS2
1Seoul National University, Seoul, South Korea , 2Chonbuk National University, Jeonju, Korea
   
PIN14  WITHDRAWN
   
PIN15  MEDICAL COST OF BACTEREMIC PNEUMOCOCCAL PNEUMONIA AND NON-BACTEREMIC PNEUMOCOCCAL PNEUMONIA FOR HOSPITALIZED PATIENTS IN KOREA, 2002-2005 
Kim SA1, Lee SY2, Batmunkh N3, Kilgore PE3, Ki MR4
1International Vaccine Institute; Graduate School of Public Health, Seoul National University, Seoul, South Korea, 2Health Insurance Research Center, Seoul, South Korea, 3International Vaccine Institute, Seoul, South Korea, 4Eulji University School of Medicine, Daejeon, South Korea 
   
INFECTION Health Care Use & Policy Studies
PIN16  EFFECT OF DISEASE AWARENESS COMMUNICATION OF HUMAN PAPILLOMAVIRUS (HPV) VACCINE ON PUBLIC PERCEPTIONS AND VACCINATION DECISION 
Putchong C1, Udomsook K1, Sumpradit N2, Khanabkaew K2, Teerawattananon Y1
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Food and Drug Administration, Nonthaburi, Thailand 
   
PIN17  OUTPATIENT ANTIBIOTIC CONSUMPTION TRENDS IN FIVE MUNICIPAL WARDS OF DELHI, INDIA 
Kotwani A1, Holloway K2, RoyChaudhury R3
1V.P.Chest Institute, Delhi, India, 2World Health Organisation, Geneva, Switzerland, 3Indraprastha Apollo Hospitals, New Delhi, India 
   
PIN18  WITHDRAWN
   
CONCEPTUAL PAPERS & RESEARCH ON METHODSCost Methods
PMC1  TOWARD AN ADAPTED REFERENCE CASE FOR DEVELOPING COUNTRIES: INCORPORATING DONOR FUNDING IMPACTS IN COST-EFFECTIVENESS ANALYSIS 
Gauvreau CL1, Ungar WJ2, Cohen-Kohler JC1
1University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, ON, Canada 
   
CONCEPTUAL PAPERS & RESEARCH ON METHODSDatabases & Management Methods
PMC2  DEVELOPMENT OF THAI HEALTH TECHNOLOGY ASSESSMENT DATABASE 
Maitreemit P, Sribundit N
Silpakorn University, Nakornpathom, Nakornpatom, Thailand 
   
CONCEPTUAL PAPERS & RESEARCH ON METHODS Patient-Reported Outcomes Methods
PMC3  HEALTH STATES VALUES IN THE THAI GENERAL POPULATION: WHAT FACTORS INFLUENCE THE RATE OF INCONSISTENT RESPONSES? 
Tongsiri S1, Cairns JA2
1London School of Hygiene and Tropical Medicine, London, United Kingdom, 2London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK, United Kingdom 
   
PMC4  KOREAN VALUATION OF EQ-5D HEALTH STATES USING TIME TRADE OFF METHOD 
Nam HS1, Lee YK2, Kim KY1, Kweon IS1, Kind P3, Chuang LH3, Kweon SS4, Yang HK1
1Chungnam National University, Daejeon, South Korea, 2Korea Centers for Disease Control and prevention, Seoul, South Korea, 3University of York, York, United Kingdom, 4Chonnam National University Hwasun Hospital, Chonnam province, South Korea 
   
PMC5  QUALITY OF LIFE MEASUREMENT IN CURRENT CLINICAL TRIALS: FOCUS ON CHRONIC DISEASES 
Bhanderi M, Singh N, Kumar R, Chawla A, Sehgal M
Heron Health Private Ltd, Chandigarh, India 
   
PMC6  IS UTILITY A LINEAR FUNCTION OF LONGEVITY? 
Knoph Kvamme M, Kristiansen IS
University of Oslo, Oslo, Norway 
   
CONCEPTUAL PAPERS & RESEARCH ON METHODSStudy & Methods Design
PMC7  A BAYESIAN ADAPTIVE DESIGN FOR EVALUATION OF THE GAP BETWEEN EFFICACY AND ERROR-ADJUSTED EFFECTIVENESS 
Moriwaki K1, Kamae I2, Yanagisawa S1, Nagase H3
1Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan, 2Keio University Graduate School of Health Management, Fujisawa, Kanagawa, Japan, 3Kobe University School of Medicine, Kobe, Hyogo, Japan 
   
PMC8  ESTIMATING A SOCIETAL VALE FOR A CEILING THRESHOLD IN THAILAND: A CASE STUDY OF MEASURING WILLINGESS-TO-PAY PER QUALITY- ADJUSTED LIFE YEAR 
Thavorncharoensap M, Natanant S, Kulpeng W, Teerawattananon Y
Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand 
   
PMC9  BIAS OF INDIRECT COMPARISON META-ANALYSIS WHEN USING RATIO AS EFFECT MEASUREMENT 
Shau WY1, Hsieh SC2
1Center for Drug Evaluation, Taipei, Taipei, Taiwan, 2National Taiwan University College of Public Health, Taipei City, Taiwan 
   
MENTAL HEALTHClinical Outcomes Studies
PMH1  EFFICACY, SAFETY AND RESOURCE USE IN PATIENTS SWITCHED DIRECTLY TO RISPERIDONE MICROSPHERES: EVIDENCE FROM CHINESE SAMPLES 
Li HC1, Gu NF2, Dong P3
1China Pharmaceutical University, Nanjing, Jiangsu, China, 2Shanghai Mental Health Center, Shanghai, Shanghai, China, 3Xi'an-Janssen Pharmaceutical Ltd, Beijing, Beijing, China 
   
MENTAL HEALTHCost Studies
PMH2  COST ANALYSIS BETWEEN VALPROATE AND LITHIUM IN THE MANAGEMENT OF BIPOLAR DISORDER: RESULTS FROM A MULTINATIONAL STUDY (VALID STUDY – VALPROATE VERSUS LITHIUM IN BIPOLAR DISORDERS) 
Li SC1, Nguyen T2
1University of Newcastle, Callaghan, Australia, 2Sanofi-Aventis, Paris, France 
   
PMH3  COST-EFFECTIVENESS OF ESCITALOPRAM COMPARED TO VENLAFAXINE AND FLUVOXAMINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN SINGAPORE 
Xie F1, Despiégel N2, Danchenko N2, Hansen K2
1McMaster University, Hamilton, Ontario, Canada, 2Lundbeck SAS, Paris, France 
   
PMH4  ECONOMIC ASSESSMENT OF THREE COMMONLY USED ANTIPSYCHOTIC AGENTS IN THE PUBLIC SECTOR OF HONG KONG USING A DECISION ANALYTIC MODEL 
Lee KK, Lee VWY
The Chinese University of Hong Kong, Shatin, Hong Kong 
   
PMH5  COST-EFFECTIVENESS ANALYSIS OF FLUVOXAMINE IN THE TREATMENT OF SOCIAL ANXIETY DISORDER (SAD) 
Makino K, Kamei M
Showa University, Shinagawa, Tokyo, Japan 
   
PMH6  COST EFFECTIVENESS OF LONG-ACTING RISPERIDONE INJECTION VERSUS ALTERNATIVE ATYPICAL ANTIPSYCHOTIC AGENTS IN PATIENTS WITH SCHIZOPHRENIA IN CHINA 
Li M1, Yang L2, Tao L2, Dong P3
1Suzhou Guangji Hospital, Su Zhou, Jiang Su, China, 2Peking University, Beijing, Beijing, China, 3Xian-Janssen Pharmaceutical Ltd, Beijing, Beijing, China 
   
PMH7  ECONOMIC EVALUATION OF PALIPERIDONE ER IN THE TREATMENT OF PATIENTS WITH AN ACUTE EXACERBATION OF SCHIZOHPHRENIA IN KOREA 
Suh GH
Hallym University Medical Center Hangang Sacred Heart Hospital, Seoul, Seoul, South Korea 
   
PMH8  ECONOMIC AND CLINICAL CONSEQUENCES ASSOCIATED WITH POTENTIAL DRUG-DRUG INTERACTIONS BETWEEN ANTIPSYCHOTICS AND CONCOMITANT MEDICATIONS IN PATIENTS WITH SCHIZOPHRENIA 
Guo JJ1, Kelton CM1, Patel NC2, Wu JH3, Jing Y1, Fan H4, Keck P1
1University of Cincinnati, Cincinnati, OH, USA, 2University of Georgia, Augusta, GA, USA, 3Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA, 4Covance Inc, Sun Prairie, WI, USA 
   
PMH9  ECONOMIC COSTS OF ALCOHOL-RELATED ABSENTEEISM AND PRESENTEEISM IN THAILAND 
Thitiboonsuwan K1, Lertpitakpong C1, Yothasamut J1, Thavorncharoensap M1, Teerawattananon Y1, Chaikledkaew U2
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand 
   
PMH10  ECONOMIC IMPACT ON HEALTH CARE COST DUE TO ALCOHOL DRINKING AMONG THAI POPULATION 
Neramitpitagkul P1, Lertpitakpong C1, Yothasamut J1, Thavorncharoensap M1, Chaikledkaew U2, Teerawattananon Y1
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand 
   
PMH11  THE COSTS OF ALZHEIMER'S DISEASE TREATMENT IN TAIWAN 
Chan ALF
Chimei medical center, Tainan, Taiwan 
   
PMH12  TREATMENT COST AND COMORBIDITIES ASSOCIATED WITH OBESITY AMONG MEDICAID PATIENTS WITH BIPOLAR DISORDER 
Guo JJ1, Kelton CM1, Jing Y1, Patel NC2
1University of Cincinnati, Cincinnati, OH, USA, 2University of Georgia, Augusta, GA, USA 
   
PMH13  A COMPARISION OF HEALTH CARE UTILIZATION AND COST OF CHILDREN AND ADOLESCENTS WITH BIPOLAR DISORDER TREATED WITH ATYPICAL ANTIPSYCHOTIC MONOTHERAPY VERSUS MOOD STABILIZER MONOTHERAPY 
Jing Y1, Guo JJ1, Patel NC2, Heaton PC1, Li H3, Kelton CM1
1University of Cincinnati, Cincinnati, OH, USA, 2University of Georgia, Augusta, GA, USA, 3Bristol-Myers Squibb Company, Singapore, Singapore 
   
MENTAL HEALTHHealth Care Use & Policy Studies
PMH14  EFFICACY AND SAFETY OF ORAL ATYPICAL ANTIPSYCHOTICS FOR SCHIZOPHRENIA: A META-ANALYSIS INCLUDING PALIPERIDONE EXTENDED-RELEASE 
Jones MP1, Nicholl D2, Trakas K3
1Macquarie University, North Ryde, NSW, Australia, 2Johnson & Johnson, Raritan, NJ, USA, 3Johnson & Johnson, Toronto, ON, Canada 
   
PMH15  ANALYSIS OF POTENTIAL DRUG-DRUG INTERACTION PAIRS ASSOCIATED WITH ANTIPSYCHOTICS AMONG MEDICAID PATIENTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER, OR BIPOLAR DISORDER 
Guo JJ1, Patel NC2, Jing Y1, Kelton CM1, Fan H3, Keck P1
1University of Cincinnati, Cincinnati, OH, USA, 2University of Georgia, Augusta, GA, USA, 3Covance Inc, Sun Prairie, WI, USA 
   
PMH16  CHANGES OF HOSPITAL SERVICE USE IN SCHIZOPHRENIA PATIENTS TREATED WITH LONG-ACTING INJECTABLE RISPERIDONE: A ONE-YEAR MIRROR IMAGE STUDY USING A POPULATION-BASED DATABASE IN TAIWAN 
Chang HC1, Tang CH1, Su KP2, Tsai SJ3, Yen FC4, Chang CL1, Hung ST1
1Taipei Medical University, Taipei, Taiwan, 2China Medical University Hospital, Taichung, Taiwan, 3Taipei Veterans General Hospital, Taipei, Taiwan, 4Cheng-Hsin Rehabilitation Medical Center, Taipei, Taiwan 
   
PMH17  OFF-LABEL USE OF SECOND-GENERATION ANTIPSYCHOTICS AMONG ADULT PATIENTS WITH BIPOLAR DISORDER IN A LARGE MANAGED CARE POPULATION 
Demland JA, Guo JJ, Kelton CM, Jing Y, Wigle PR
University of Cincinnati, Cincinnati, OH, USA 
   
MUSCULAR-SKELETAL DISORDERSClinical Outcomes Studies
PMS1  EFFICACY AND GASTROINTESTINAL SAFETY OF CELECOXIB COMPARING TO OTHER NSAIDS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS 
Lee J1, Park S2, Lee J3, Ko S4
1Korea University, Seoul, South Korea, 2Yonsei university, Seoul, South Korea, 3Seoul National University, Seoul, South Korea, 4Pfizer Korea, Seoul, South Korea 
   
PMS2  THE ROLE OF RISK FACTORS IN MORTALITY AFTER FEMORAL NECK FRACTURE 
Sebestyén A1, Boncz I2, Sándor J2, Nyárády J2, Betlehem J2, Oláh A2, Vas G2, Tóth F2
1National Health Insurance Fund Administration, Budapest, Hungary, 2University of Pécs, Pécs, Hungary 
   
MUSCULAR-SKELETAL DISORDERSCost Studies
PMS3 COST-BENEFIT ANALYSIS OF MANAGEMENT STRATEGIES TO REDUCE MOTORCYCLE ROAD TRAFFIC INJURIES
Srijariya W, Riewpaiboon A, Chaikledkaew U, Pongcharoensuk P
Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand
   
PMS4 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB FOR RHEUMATOID ARTHRITIS IN TAIWAN 
Lin HY1, Chang DM2, Chen DY3, Cheng TT4, Huang CM5, Lou SF6, Su CC7, Tsai WC8, Tseng JC9, Wei CC10, Yang L11, Hazard S12
1Taipei Veterans General Hospital, Taipei, Taiwan, 2Tri-service General Hospital, Taipei, Taiwan, 3Taichung Veterans General Hospital, Taichung, Taiwan, 4Chang Gung Memorial Hospital, Koushung, Taiwan, 5China Medical University Hospital, Taichung, Taiwan, 6Chang Gung Memorial Hospital, Linkou, Taiwan, 7Changhua Christian Hospital, Changhua, Taiwan, 8Kaoshiung Medical University Hospital, Kaoshiung, Taiwan, 9Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, 10Chung Shan Medical University Hospital, Taichung, Taiwan, 11Roche Products Ltd, Taipei, Taiwan, 12F. Hoffmann-La Roche AG, Basel, Switzerland  
   
PMS5 ECONOMIC EVALUATION ON SCREENING STRATEGIES AND TREATMENT OPTIONS FOR POSTMENOPAUSAL OSTEOPOROSIS
Kingkaew P1, Maleewong U2, Ngarmukos C3, Teerawattananon Y1
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Mahasarakham University, Mahasarakham, Thailand, 3Ramathibodi Hospital, Bangkok, Thailand  
   
PMS6 COST-OF-ILLNESS STUDY OF HIP FRACTURE AMONG KOREAN ELDERLY WOMEN: INCIDENCE-BASED APPROACH
Kang HY1, Park SE2, Kang DR3, Kim JY1, Chang YH4, Choi WJ5, Moon SH6, Yang KH6, Park JY7, Kwon SY8
1Yonsei University, Seoul, South Korea, 2Health Insurance Review & Assessment Service, Seoul, Seoul, South Korea, 3Severance Hospital Clinical Trials Center, Seoul, South Korea, 4Department of Public Health, Graduate School, Yonsei University, Seoul, South Korea, 5Health Insurance Review Agency, Seoul, South Korea, 6Department of Orthopedics, College of Medicine, Yonsei University, Seoul, South Korea, 7Konkuk University, Seoul, South Korea, 8The Catholic University of Korea, Seoul, South Korea
   
PMS7 EVALUATION THE FINANCIAL BURDEN OF ILLNESS OF FEMORAL NECK FRACTURE IN CONNECTION WITH COMPLICATION AND FRACTURE TYPE 2 YERS FOLLOW UP UNDER 60
Sebestyén A1, Nyárády J2, Tóth F2, Betlehem J2, Vas G2, Boncz I2
1National Health Insurance Fund Administration, Budapest, Hungary, 2University of Pécs, Pécs, Hungary
   
PMS8  HEALTH RESOURCE UTILIZATION OF OSTEOPOROSIS PATIENTS AT PHRAMONGKUTKLAO HOSPITAL
Werayingyong P1, Pongcharoensuk P2, Kamolsilp M3
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand, 3Phramongkutklao Hospital, Rathavi, Bangkok, Thailand
   
PMS9  TOTAL OR PARTIAL KNEE REPLACEMENT? A COST-EFFECTIVENESS ANALYSIS IN PATIENTS WITH KNEE OSTEOARTHRITIS BASED ON TWO-YEAR PRELIMINARY DATA
Xie F1, Luo N2, Lo NN3, Lee HP2
1McMaster University, Hamilton, Ontario, Canada, 2National University of Singapore, Singapore, Singapore, 3Singapore General Hospital, Singapore, Singapore
   
MUSCULAR-SKELETAL DISORDERSPatient-Reported Outcomes Studies
PMS10  WITHDRAWN
   
PMS11  MEASURING QUALITY OF LIFE IN PATIENTS WITH FOCAL LOWER LIMB SPASTICITY 
Halstead M1, Wilson J2, Kovacs G2, Adams J2, Schultz M1, Napier-Flood F3, Rogers J1
1Allergan Australia, Gordon, NSW, Australia, 2IMS Health, St Leonards, NSW, Australia, 3Tobermory Scientific Research, St Leonards, NSW, Australia 
   
NEUROLOGICAL DISORDERSCost Studies
PND1  THE COST OF HOME-BASED CARE FOR THAI ELDERLY WITH DEMENTIA IN A THAI UNIVERSITY HOSPITAL 
Turongkaravee S1, Chaikledkaew U1, Chansirikarnjana S2, Pongchareonsuk P3, Krairit O2
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Ramathibodi Hospital, Bangkok, Thailand, 3Mahidol University, Bangkok, Thailand 
 
NEUROLOGICAL DISORDERSPatient-Reported Outcomes Studies
PND2  PREDICTORS OF MEDICATION ADHERENCE IN OLDER ADULTS WITH INSOMNIA 
Kulkarni AS1, Patel I2, Anderson RT3, Balkrishnan R2
1Express Scripts Inc, Maryland Heights, MO, USA, 2The Ohio State University, Columbus, OH, USA, 3Wake Forest University School of Medicine, Winston Salem, NC, USA 
   
PND3  Withdrawn
   
PND4  THE DISEASE BURDEN OF NEUROPATHIC PAIN 
Huang Y1, Cui L1, Liu G2, Duttagupta S3, Sun F4
1Chinese Academy of Medical Sciences Peking Union Medical College Hospital, Beijing, China, 2Peking University, Beijing, China, 3Pfizer Inc, New York, NY, USA, 4Pfizer Investment Co., Limited, Beijing, China 
   
NEUROLOGICAL DISORDERSHealth Care Use & Policy Studies
PND5  EVALUATING AN ONLINE FREEWARE CALCULATOR FOR ANALYZING COST EFFECTIVENESS DATA FOR FORMULARY DRUG CLASSES 
McGhan W1, Peterson AM2
1University of the Sciences, Philadelphia, PA, USA, 2University of the Sciences in Philadelphia, Philadelphia, PA, USA 
   
RESPIRATORY-RELATED DISORDERSClinical Outcomes Studies
PRS1  COMPARISON OF EFFECTIVENESS BETWEEN THE PHARMACOTHERAPIES FOR THE SMOKING CESSATION: VARENICLINE, BUPROPION, AND NICOTINE REPLACEMENT THERAPY 
Joe KH1, Kim DJ2, Kim CH3, Bae JY4, Song HJ4, Lee EK4
1Eulji University, seongnam, kyeonggi, South Korea, 2The catholic university of Korea, Holy family hospital, Bucheon, South Korea, 3Family Medicine of Seoul Paik Hospital, seoul, South Korea, 4Sook Myung Women's University, Seoul, South Korea 
   
PRS2  SMOKING BEHAVIOR AND REASONS FOR SMOKING: A SURVEY OF THAI MALE SMOKERS IN MAJOR CITIES 
Leartsakulpanitch J
Pfizer (Thailand) Ltd, Bangkok, Thailand 
   
PRS3  SMOKERS NEED MORE MEDICAL & FAMILY SUPPORT WHEN ATTEMPTING TO QUIT SMOKING 
Pathan AN, Naqvi SAA
Pfizer Laboratories Limited, Karachi, Sindh, Pakistan 
   
PRS4  SMOKING EPIDEMIC IN PAKISTAN, A LOOK AT THE TIP OF THE ICEBERG 
Pathan AN, Naqvi SAA
Pfizer Laboratories Limited, Karachi, Sindh, Pakistan 
 
RESPIRATORY-RELATED DISORDERSCost Studies
PRS5  BUPROPION AND NORTRIPTYLINE IN SMOKING CESSATION: COST-EFFECTIVENESS EVIDENCE IN THAILAND 
Thavorn K1, Chaiyakunapruk N2
1University of Toronto, Toronto, Ontario, Canada, 2Naresuan University, Muang, Phitsanulok, Thailand 
   
PRS6  COST-EFFECTIVENESS ANALYSIS OF SMOKING CESSATION PHARMACOTHERAPIES IN AUSTRALIA 
Bhatti TA1, Makino K1, Guarnieri C1, Gordois A1, Cotter T2, Perez DA2, Bishop JF2, Glass P2, Fong L1
1IMS Health, St Leonards, New South Wales, Australia, 2Cancer Institute NSW, Eveleigh, New South Wales, Australia
   
PRS7  ECONOMIC EVALUATION OF VARENICLINE IN TAIWAN 
Wen CP1, Wang MT2, Chu CHY3, Sun CC3, Lin SSF3
1National Health Research Institutes, Zhunan Town, NA, Taiwan, 2National Defense Medical Center, Taipei, NA, Taiwan, 3Pfizer Taiwan, Taipei County, NA, Taiwan 
   
PRS8  COST-EFFECTIVENESS EVALUATION OF SYMBICORT®MAINTENANCE AND RELIEVER THERAPY (SMART) COMPARED WITH TRADITIONAL ASTHMA TREATMENTS FROM THE PERSPECTIVE OF THAI HEALTHCARE PROVIDERS. 
Boonsawat W
Khon Kaen University, Khon Kaen, Khon Kaen, Thailand 
   
PRS9  SMOKING IN THAILAND: A FINANCIAL BURDEN OF KEY SMOKING-RELATED DISEASES 
Leartsakulpanitch J1, Salole E2, Ngantawee W1
1Pfizer (Thailand) Ltd, Bangkok, Thailand, 2Pfizer (Australia), Sydney, Australia 
   
PRS10  ESTIMATING THE ANNUAL COST OF SMOKING-RELATED DISEASES IN INDONESIA 
Sutrisna B, Surtidewi L, Jusuf A, Hudoyo A, Kusmana D, Setianto B
Indonesia University, Jakarta, Indonesia 
   
RESPIRATORY-RELATED DISORDERSPatient-Reported Outcomes Studies
PRS11  COMPARISON OF TWO UTILITY MEASUREMENT TECHNIQUES: TIME TRADED OFF AND VISUAL ANALOGUE SCALE 
Natanant S1, Kulpeng W2, Thavorncharoensap M3, Teerawattananon Y3
1Health Intervention and Technology Assessment Program(HITAP), Muang, Nontaburi, Thailand, 2Health Intervention and Technology Assessment Program(HITAP), Muang, Nonthaburi, Thailand, 3Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand 
 
RESPIRATORY-RELATED DISORDERSHealth Care Use & Policy Studies
PRS12  GENDER DISPARITY OF CUTANEOUS HYPERSENSITIVITY REACTION IN U.S. FOOD AND DRUG ADMINISTRATION NEW DRUG APPLICATION REVIEW 
Lee E1, Johann-Liang R2
1Howard University School of Pharmacy, Washington, DC, USA, 2U.S. Department of Health and Human Services, Rockville, MD, USA 
   
PRS13  SMOKING AND ASTHMA: THE ADDITIONAL ASTHMA BURDEN ASSOCIATED WITH CURRENT SMOKERS 
Campbell JD, Watanabe JH, Sullivan SD
University of Washington, Seattle, WA, USA 
   
PRS14  MEDICATION PERSISTENCE AND ADHERENCE TO INHALED CORTICOSTEROID TREATMENT AMONG CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS 
Akazawa M
University of Tokyo, Bunkyo-ku, Tokyo, Japan 
   
PRS15  GENDER DIFFERENCES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE-RELATED VISITS: BASED ON NAMCS AND NHAMCS FROM 1995-2004 
Suh DC1, Choi IS1, Kim CM2, Nam EW1, Lau H3
1Rutgers University, Piscataway, NJ, USA, 2Catholic University, Seoul, Suhcho-gu, South Korea, 3Novartis Pharmaceuticals, East Hanover, NJ, USA 
   
PRS16  CAN SMOKE-FREE POLICIES BE INTRODUCED IN CHINA? AN APPLICABILITY ASSESSMENT OF EVIDENCE-BASED HEALTH POLICY 
Hiller JE1, Au N1, Wang S1, Meng Q2
1University of Adelaide, Adelaide, South Australia, Australia, 2Shandong University China, Jinan, Shandong, China 
   
PRS17  DOES KEEPING A MEDICAL COST DIARY AFFECT THE MEDICAL UTILIZATION? 
Chae S1, Ko S2
1Korea Institute for Health and Social Affairs, Seoul, South Korea, 2Pfizer Korea, Seoul, South Korea 
 
SENSORY SYSTEMS DISORDERSCost Studies
PSS1  ANALYSIS OF COST-UTILITY AND BUDGET IMPACT ON COCHLEAR IMPLANTATION FOR PROFOUNDLY BILATERAL HEARING LOSS PATIENTS IN THAILAND: A SIMULATION STUDY 
Kingkaew P1, Werayingyong P1, Youngkong S1, Riewpaiboon W2, Kanchanalarp C3, Tungkeeratichai J3, Potaporn M4, Teerawattananon Y1
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Sirindhorn National Medical Rehablilitation Center, Muang, Nonthaburi, Thailand, 3Ramathibodi hospital, Ratchathewi, Bangkok, Thailand, 4Rajavithi hospital, Ratchathewi, Bangkok, Thailand 
   
PSS2  WITHDRAWN
 
SENSORY SYSTEMS DISORDERSHealth Care Use & Policy Studies
PSS3  ECONOMIC BURDENT OF ATOPIC MANIFESTATIONS IN PATIENTS WITH ATOPIC DERMATITIS 
Suh DC1, Kim CM2, Choi IS1, Sung J3, Huang J1, Gause D4
1Rutgers University, Piscataway, NJ, USA, 2Catholic University, Seoul, Suhcho-gu, South Korea, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 4Novartis Pharmaceuticals, East Hanover, NJ, USA 
   
PSS4  NEEDS ASSESSMENT OF MOTHERS WITH CHILDREN AFFECTED BY DERMATITIS 
Uras C, Andreoli E, Alfani S, Tabolli S
IDI IRCCS, Rome, Italy 
   
SYSTEMIC DISORDERS/CONDITIONSClinical Outcomes Studies
PSY1  WITHDRAWN
   
SYSTEMIC DISORDERS/CONDITIONSCost Studies
PSY2  PATHOGEN SAFETY AND THE COST EFFECTIVENESS OF ADVATE IN SOUTH KOREA 
Epstein JD1, Li-McLeod J1, Bang J2
1Baxter BioScience, Westlake Village, CA, USA, 2Baxter Healthcare Korea, Seoul, Seoul, South Korea 
PSY3  ECONOMIC EVALUATION OF ORAL CHELATOR WITH DEFERASIROX VERSUS INFUSIONAL DEFEROXAMINE
Kim J
Seoul National University, Seoul, South Korea 
   
SYSTEMIC DISORDERS/CONDITIONSPatient-Reported Outcomes Studies
PSY4  HEALTH RELATED QUALITY OF LIFE IN PEMPHIGUS 
Tabolli ST1, Paradisi A2, Ferri R3, Di Pietro C1, Abeni D1, Didona B2, Cianchini G2
1IDI IRCCS, Rome, Italy, 2IDI-IRCCS, Rome, Italy, 3IDI-IRCCS\, Rome, Italy 
   
SYSTEMIC DISORDERS/CONDITIONSHealth Care Use & Policy Studies
PSY5  PATIENT SELECTION CRITERIA FOR PATIENTS WITH DISCOGENIC LOW BACK PAIN TREATED WITH INTRADISCAL ELECTROTHERMAL THERAPY (IDET): ENSURING APPROPRIATE CARE AND EFFICIENT RESOURCE UTILIZATION 
Kloth DS1, Fenton DS2, Block JE3, Schultz M4, Rohan B5
1Connecticut Pain Care, Danbury, CT, USA, 2Mayo Clinic, Jacksonville, FL, USA, 3Jon E Block PhD Inc, San Francisco, CA, USA, 4Pharmaccess Inc, Westmount, QC, Canada, 5Smith&Nephew Inc, Memphis, TN, USA 
   
URINARY/KIDNEY DISORDERSClinical Outcomes Studies
PUK1  COMPARING THE CLINICAL OUTCOMES FOLLOWING URINARY INCONTINENCE TREATMENT 
Olah A1, Katona G2, Betlehem J3, Muller A1, Roznar J4, Palfi I1, Cucz P1, Varadyne Horvath A1, Sebestyén A5, Kriszbacher I3, Bódis J3, Vas G3, Boncz I3
1University of Pecs, Pecs, Hungary, 2Hospital Baja, Baja, Hungary, 3University of Pécs, Pécs, Hungary, 4University of Pecs, Szombathely, Hungary, 5National Health Insurance Fund Administration, Pecs, Hungary 
   
URINARY/KIDNEY DISORDERSCost Studies
PUK2  IN THE UK, AN INCREASED UTILISATION OF PERITONEAL DIALYSIS THERAPY COULD LEAD TO AN INCREASE IN THE NUMBER OF PATIENTS BEING TREATED FOR RENAL REPLACEMENT THERAPY (RRT) 
Walker DR1, Sondhi S2
1Baxter Healthcare Corporation, McGaw Park, IL, USA, 2Baxter Healthcare, Thetford, United Kingdom 
   
PUK3  ECONOMIC IMPACT OF OVERACTIVE BLADDER SYMPTOMS IN JAPAN 
Inoue S1, Kobayashi M1, Sugaya K2
1Crecon Research and Consulting Inc, Shibuya-ku, Tokyo, Japan, 2University of the Ryukyus, Nishihara, Okinawa, Japan 
   
URINARY/KIDNEY DISORDERSPatient-Reported Outcomes Studies
PUK4  MODELLING UTILITY TARIFFS FROM A MALAYSIAN PATIENT POPULATION 
Goh A1, Tan WH2, Aryani Md. Yusof F3, Lim TO3
1ClinResearch Sdn Bhd, Kuala Lumpur, Malaysia, 2PAREXEL-APEX China, Co., Ltd, Shanghai, China, 3Kuala Lumpur Hospital, Kuala Lumpur, Malaysia 
   
PUK5  QUALITY OF LIFE ON DIALYSIS IN MALAYSIA 
Aryani Md.Yusof F1, Goh A2
1Clinical Research Centre, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia, 2ClinResearch Sdn Bhd, Kuala Lumpur, Malaysia 
   
URINARY/KIDNEY DISORDERSHealth Care Use & Policy Studies
PUK6  LIBERALISATION OF HEALTHCARE AND ITS IMPACT ON PROVISION, EFFICIENCY AND EQUITY: THE EXPERIENCE OF DIALYSIS IN MALAYSIA 
Lim TO1, Goh A2, Morad Z3, Mohd Ghazali R4
1Kuala Lumpur Hospital, Kuala Lumpur, Malaysia, 2ClinResearch Sdn Bhd, Kuala Lumpur, Malaysia, 3International Medical University, Kuala Lumpur, Malaysia, 4Penang Hospital, Georgetown, Pulau Pinang, Malaysia 
   
PUK7  DIALYSIS FACILITY CHARACTERISTICS INFLUENCE THE USE OF HOME DIALYSIS IN THE U.S. 
Walker DR, Inglese GW, Just PM
Baxter Healthcare Corporation, McGaw Park, IL, USA 
   
3rd Asia-Pacific Conference Main Page

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
©2010 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
Website design by Eagle Systems USA, Inc.